Top Venture Capital Firms in Israel: Investment Opportunities and How to Connect

Israel’s venture capital industry has matured significantly over the past decade, establishing itself as a global powerhouse second only to Silicon Valley in terms of per capita investment activity. In 2026, the ecosystem continues to thrive despite global economic uncertainties, with israel venture capital funds managing over $100 billion in assets under management collectively.

The Israeli VC market is characterized by several unique features that distinguish it from other global innovation hubs. First, there’s an exceptional density of technical talent, largely stemming from elite military intelligence units like 8200 and cybersecurity divisions. This creates a pipeline of entrepreneurs with deep technological expertise and experience working on complex, mission-critical systems.

Second, Israeli VCs typically take a hands-on approach with their portfolio companies, providing not just capital but strategic guidance, international market access, and operational support. This mentorship culture has contributed to the ecosystem’s high success rate and has made Israeli startups particularly attractive to strategic acquirers and later-stage investors.

Third, the market demonstrates strong sector concentrations in cybersecurity, enterprise software, fintech, digital health, and automotive technology. These specializations have created deep expertise clusters and vertical-specific networks that benefit both investors and entrepreneurs.

The regulatory environment in Israel has also evolved to support venture investment, with government programs like the Israel Innovation Authority providing matching funds, R&D grants, and incentives that de-risk early-stage investments. This public-private partnership model has amplified the impact of venture capital across the ecosystem.

Understanding which firms lead the Israeli VC landscape is crucial for anyone seeking to invest in or partner with these organizations. The following represents the most influential and active top vcs in israel as of 2026, based on assets under management, deal volume, exit performance, and ecosystem influence.

Jerusalem Venture Partners stands as one of Israel’s most established and successful venture capital firms, founded in 1993. With over $2 billion in assets under management across multiple funds, JVP has been a cornerstone of the Israeli innovation ecosystem for more than three decades.

JVP’s investment thesis centers on early to growth-stage companies in cybersecurity, enterprise software, digital media, and data infrastructure. The firm has demonstrated remarkable foresight in identifying technology trends before they become mainstream, having invested in companies like CyberArk (NASDAQ: CYBR), Qumranet (acquired by Red Hat), and BillGuard (acquired by Prosper).

What distinguishes JVP is its entrepreneurial approach to ecosystem building. The firm operates innovation centers in Jerusalem and Beer Sheva, creating physical hubs that bring together entrepreneurs, corporations, and government entities. These centers, including the JVP Media Quarter and the JVP Cyber Labs, provide portfolio companies with world-class facilities, mentorship, and access to potential customers and partners.

JVP typically invests between $5 million and $15 million in initial rounds, with capacity for significant follow-on investments as companies scale. The firm maintains an active international presence, with offices in New York and strong relationships with major U.S. institutional investors and strategic partners.

For foreign investors, JVP offers co-investment opportunities through its fund structures and has established track records of generating strong returns. The firm’s portfolio includes over 140 companies, with more than 20 having achieved unicorn status or successful public market exits.

OurCrowd has revolutionized access to Israeli venture capital by pioneering an equity crowdfunding platform that enables accredited investors worldwide to participate in vetted Israeli and global startups. Founded in 2013, OurCrowd has grown to become one of the most active venture investors globally, with over $2 billion deployed across 300+ portfolio companies and funds.

The platform democratizes venture capital by allowing individual investors to participate alongside institutional investors with minimum investments as low as $10,000. This model has attracted over 90,000 registered investors from more than 195 countries, creating a global community interested in Israeli innovation.

OurCrowd’s investment approach combines rigorous due diligence—reviewing over 3,000 opportunities annually and selecting approximately 3%—with post-investment support through its OurCrowd Labs accelerator and corporate partnership programs. The firm invests across sectors including cybersecurity, digital health, fintech, foodtech, and climate technology.

Notable portfolio companies include Beyond Meat (NASDAQ: BYND), Lemonade (NYSE: LMND), Freightos, and Innoviz Technologies. OurCrowd also manages funds of funds that provide exposure to top-tier Israeli and international VCs, offering diversification for investors seeking broader market exposure.

The platform’s transparency, regular investor communications, and secondary market capabilities make it particularly attractive for foreign investors new to the Israeli ecosystem who want structured access with built-in support and education.

Aleph represents the new generation of Israeli venture capital, founded in 2013 by veterans of leading tech companies and previous VC firms. With approximately $600 million under management, Aleph focuses on seed and Series A investments in enterprise software, developer tools, and infrastructure companies.

The firm’s investment philosophy emphasizes backing exceptional founders building global category-defining companies from Israel. Aleph typically invests $3-10 million in initial rounds and has demonstrated strong conviction in its portfolio through significant follow-on investments.

Aleph’s portfolio includes prominent companies like Velocity, Cider Security, Armis Security (valued at $3.4 billion), and Lemonade. The firm has achieved multiple unicorn exits and maintains one of the highest portfolio valuations among Israeli early-stage investors.

What sets Aleph apart is its partnership approach—the firm works with a concentrated portfolio of approximately 30-35 companies at any given time, allowing deep engagement with each founder team. Partners bring operational experience from companies like Google, Microsoft, and successful Israeli startups, providing tactical guidance on product development, go-to-market strategy, and international expansion.

Pitango is Israel’s largest venture capital firm, managing over $2.8 billion across multiple funds focused on different stages and sectors. Founded in 1993, Pitango has evolved into a multi-stage platform with dedicated early-stage, growth, and healthtech funds.

The firm invests across the full lifecycle of technology companies, from seed-stage startups to pre-IPO growth companies. This multi-stage capability allows Pitango to support companies from inception through public markets, providing capital continuity that many entrepreneurs value.

Pitango’s sector focus includes enterprise software, cybersecurity, fintech, digital health, and consumer technology. The firm has backed iconic Israeli companies including Wix (NASDAQ: WIX), Payoneer (NASDAQ: PAYO), Orcam, and Fundbox.

With offices in Tel Aviv, Herzliya, and New York, Pitango maintains strong connections to both Israeli innovation and U.S. capital markets. The firm’s growth fund specifically targets companies preparing for late-stage financing or public market entry, filling an important gap in the Israeli ecosystem.

Pitango HealthTech, launched in 2016, represents one of the largest dedicated digital health venture funds globally, with over $400 million focused exclusively on healthcare innovation. This sector specialization has positioned Pitango as a go-to investor for medical device, digital therapeutics, and health IT companies.

83North is a global venture capital firm with deep Israeli roots, managing over $1.5 billion across multiple funds. The firm invests in early and growth-stage companies across Europe, Israel, and the United States, with particular strength in enterprise software and consumer technology.

Formerly known as Greylock IL, the firm rebranded as 83North to reflect its pan-European expansion while maintaining its strong Israeli presence. The firm typically invests $5-50 million across multiple rounds, supporting companies from Series A through late-stage growth.

83North’s portfolio includes several high-profile successes including JustEat (LSE: JE), iZettle (acquired by PayPal for $2.2 billion), Mirakl, and Pendo. The firm’s global perspective and network provide Israeli companies with valuable connections across European and American markets.

The firm’s investment approach emphasizes backing ambitious founders building category-leading businesses with global potential. Partners bring extensive operational experience and maintain active involvement in portfolio company strategy, business development, and fundraising.

Viola Group stands as one of Israel’s oldest and most successful venture capital organizations, with roots dating back to 1999. The organization manages over $4 billion across multiple funds, including Viola Ventures (early-stage), Viola Growth, Viola Credit, and sector-specific funds in fintech and life sciences.

This multi-product approach allows Viola to support companies across their entire lifecycle with different capital instruments, from equity to venture debt. The firm has backed over 200 companies and achieved more than 60 exits, including prominent companies like Argus Cyber Security (acquired by Continental), Vroom (NASDAQ: VRM), and Next Insurance.

Viola’s sector expertise spans cybersecurity, enterprise software, fintech, digital health, and semiconductor technologies. The firm’s deep network includes relationships with major corporations, financial institutions, and strategic partners globally.

Viola’s team includes over 30 investment professionals with diverse backgrounds in entrepreneurship, technology, finance, and strategic consulting. This depth of expertise enables the firm to provide comprehensive support across technical, operational, and strategic dimensions.

Understanding the investment focus and strategic priorities of top venture capital firms in Israel is essential for entrepreneurs seeking funding and investors looking to partner with these firms. Israeli VCs have developed distinct sector concentrations and investment philosophies shaped by the country’s technological strengths and market dynamics.

Cybersecurity remains the dominant sector focus across the Israeli VC landscape. Firms like Jerusalem Venture Partners, Team8, YL Ventures, and Glilot Capital Partners have built specialized expertise in security technologies. This concentration reflects Israel’s unique advantages in cybersecurity, stemming from military intelligence experience, sophisticated threat environments, and deep technical expertise. Israeli cybersecurity companies raised over $4 billion in 2026, representing approximately 30% of total Israeli venture funding.

Enterprise software and B2B SaaS constitute another major focus area, with firms like Aleph, Bessemer Venture Partners Israel, and Vertex Ventures investing heavily in infrastructure, developer tools, and vertical SaaS applications. Israeli entrepreneurs excel at building technical, bottom-up products that solve complex enterprise problems, making this a natural strength area.

Digital health and life sciences have emerged as significant growth sectors, supported by dedicated funds from Pitango HealthTech, aMoon, and Orbimed Israel Partners. Israel’s strength in medical devices, digital therapeutics, and computational biology has attracted substantial capital, with the sector raising over $2 billion in 2026.

Fintech represents another concentration area, with Israeli companies excelling in payments infrastructure, embedded finance, fraud prevention, and regulatory technology. Firms like Viola Fintech and Team8 Fintech have developed sector-specific expertise and networks that provide competitive advantages.

Investment stage preferences vary across firms. Seed and Series A investors like Aleph, NFX, and Firstime Ventures typically deploy $1-10 million in early-stage companies, focusing on product-market fit and initial scaling. Growth-stage investors like Insight Partners, Stripes, and Pitango Growth invest $20-100 million in later-stage rounds, supporting international expansion and pre-IPO scaling.

Most Israeli VCs maintain a global investment mandate, seeking companies that can scale internationally rather than focusing exclusively on the domestic market. This global orientation reflects the limited size of the Israeli market and the necessity for technology companies to expand internationally to achieve meaningful scale.

For international investors seeking exposure to Israeli innovation, several structured pathways provide access to high-quality deal flow and partnerships with established israel venture capital funds. Understanding these mechanisms is crucial for optimizing investment strategy and risk management.

Direct fund investment represents the most straightforward approach for institutional investors. Most top-tier Israeli VCs raise funds from global limited partners including pension funds, endowments, sovereign wealth funds, and family offices. Minimum commitments typically range from $5 million to $25 million depending on fund size and investor type. This approach provides diversified exposure across a portfolio of companies and benefits from the VC’s expertise in sourcing, due diligence, and value creation.

Leading firms like JVP, Pitango, Aleph, and Viola maintain dedicated investor relations teams that manage LP relationships and provide regular reporting on portfolio performance. Most funds operate on a 10-year lifecycle with a 2-3 year investment period, followed by portfolio management and eventual exits.

Co-investment opportunities allow LPs to invest directly alongside VC funds in specific portfolio companies, typically with reduced or eliminated fees. This approach enables larger position sizing in high-conviction opportunities and provides more granular control over portfolio construction. Many Israeli VCs offer co-investment rights to significant LPs as part of their fund terms.

Secondary market purchases have become increasingly accessible through platforms like Forge Global, EquityZen, and SharesPost, which facilitate transactions in pre-IPO company shares. This approach allows investors to build positions in mature private companies without committing to 10-year fund cycles, though typically at premium valuations and with less favorable liquidity terms.

Platform investments through OurCrowd provide accessible entry points for accredited investors with lower minimum investments ($10,000-$50,000). While offering less institutional-grade due diligence than top-tier VCs, OurCrowd provides diversification, transparency, and educational resources valuable for investors new to the ecosystem.

Fund of funds structures managed by firms like Vintage Investment Partners and Chartered Group provide diversified exposure across multiple Israeli VC managers. This approach reduces manager selection risk and provides broader portfolio coverage, though with an additional layer of fees. Minimum investments typically start at $1-5 million for institutional fund of funds.

Strategic partnerships and venture building represent alternative approaches for corporations seeking technology access and innovation partnerships. Many Israeli VCs operate corporate venture programs or strategic partnerships that provide multinational companies with deal flow, technology scouting, and co-development opportunities.

For individual investors and smaller family offices, gaining access to top-tier Israeli VCs typically requires establishing track records through smaller platforms like OurCrowd, building relationships through ecosystem organizations like Start-Up Nation Central, or partnering with established institutional investors who can provide introductions.

Conducting thorough due diligence on Israeli venture capital partnerships requires understanding both the fund manager evaluation process and the underlying portfolio company assessment methodologies that top VCs employ.

Fund manager due diligence should evaluate several critical dimensions. Track record analysis examines historical fund performance across multiple vintages, including distributions to paid-in capital (DPI), total value to paid-in capital (TVPI), and internal rates of return (IRR). Top-quartile Israeli VCs typically generate net IRRs exceeding 20% over fund lifecycles, though performance varies significantly by vintage year and sector focus.

Team assessment evaluates partner experience, complementary skill sets, decision-making processes, and organizational stability. The strongest Israeli VCs combine entrepreneurial experience, technical expertise, and global network access. Partner tenure and alignment of interests through meaningful personal capital commitment indicate organizational stability.

Deal sourcing capabilities distinguish top performers from average funds. Elite Israeli VCs see 1,000+ opportunities annually and maintain proprietary networks that provide early access to exceptional founders. Evaluation should examine the proportion of proactive sourcing versus reactive inbound deal flow, as well as the fund’s reputation among entrepreneurs.

Value creation infrastructure includes portfolio support resources, talent networks, business development capabilities, and follow-on capital availability. Leading Israeli VCs provide hands-on operational support, introductions to potential customers and partners, and assistance with international expansion.

Portfolio company due diligence conducted by Israeli VCs typically follows rigorous processes adapted to local market conditions. Technical assessment often involves deep expertise given the sophisticated nature of Israeli technologies, with VCs employing technical advisors and portfolio CTOs to evaluate architecture, IP position, and competitive differentiation.

Market analysis examines total addressable market size, competitive landscape, and go-to-market strategy, with particular focus on international expansion capabilities since most Israeli startups must scale globally. Team evaluation emphasizes founder quality, technical capabilities, and previous entrepreneurial experience, with military intelligence unit backgrounds (particularly Unit 8200) often viewed positively.

Financial diligence examines unit economics, capital efficiency, and pathway to profitability. Israeli companies often demonstrate strong capital efficiency compared to U.S. counterparts due to lower burn rates and more conservative growth strategies.

Partnership structures for foreign investors vary by investment vehicle. Traditional limited partnership structures dominate, with 2% management fees and 20% carried interest representing standard terms for established funds, though emerging managers may offer discounted terms. Preferred returns (hurdles) of 8% are common, ensuring LPs receive preferential returns before managers participate in profits.

Side letter provisions often address specific investor requirements regarding reporting frequency, co-investment rights, advisory board participation, and fee discounts for larger commitments. Institutional investors should negotiate transparency provisions ensuring timely access to portfolio company information and fund performance metrics.

Legal and regulatory considerations include Israeli securities regulations, tax treaty implications, and currency considerations. Most Israeli VCs structure funds in Delaware or Cayman Islands jurisdictions to accommodate international investors, though underlying portfolio investments occur through Israeli entities. Qualified tax counsel should evaluate withholding tax implications and treaty benefits available to specific investor types.

Evaluating the performance of top vcs in israel requires understanding both quantitative metrics and qualitative indicators that distinguish exceptional performers from average funds. As of 2026, the Israeli VC industry has demonstrated strong long-term returns, though with significant variance across managers and vintage years.

Financial performance metrics provide the foundation for evaluation. Top-quartile Israeli VC funds have historically generated net IRRs of 25-40% for early-stage funds and 20-30% for growth-stage funds, significantly outperforming public market benchmarks. However, these returns are highly skewed, with a small number of exceptional outcomes driving portfolio returns—consistent with global venture capital dynamics.

Distributions to paid-in capital (DPI) measures actual cash returned to investors, providing insight into realization of gains rather than paper markups. Mature Israeli VC funds (vintage years 2016-2020) are now showing DPIs of 1.5x-3.0x for top performers, indicating strong cash-on-cash returns. Total value to paid-in capital (TVPI) includes both distributions and remaining portfolio valuations, with leading Israeli funds showing TVPIs of 3x-5x for maturing vintages.

Time to exit represents a critical performance factor, with Israeli companies historically achieving liquidity through acquisitions (70% of exits) or IPOs (30% of exits) within 7-10 years of initial investment. The strong M&A market, driven by strategic acquirers seeking Israeli technology, has provided consistent exit opportunities even during challenging public market conditions.

Portfolio construction outcomes reveal how well VCs have deployed capital and constructed diversified portfolios. Top Israeli VCs typically invest in 20-30 companies per fund, with the expectation that 2-3 exceptional outcomes will drive the majority of returns, 5-7 companies will generate moderate returns, and the remainder will fail or return minimal capital.

Concentration metrics examine whether funds have achieved appropriate position sizing in their best performers. Successful Israeli VCs demonstrate disciplined follow-on investment strategies, increasing ownership in breakout companies while managing risk in underperformers.

Operational value creation indicators assess how effectively VCs support portfolio company development. Metrics include revenue growth rates, customer acquisition efficiency, capital efficiency (revenue per dollar raised), time to product-market fit, and successful international expansion rates.

Leading Israeli VCs demonstrate portfolio company revenue growth rates averaging 150-300% annually in early years, declining to 50-100% as companies mature. Capital efficiency metrics show Israeli companies often achieve Series B stage ($10M+ ARR) with 30-40% less total capital raised compared to U.S. equivalents, reflecting disciplined spending cultures.

Market reputation indicators include entrepreneur NPS scores, repeat founder rates, and competitive positioning in desired deals. Elite Israeli VCs win 40-60% of competitive deals they pursue, indicating strong founder preference. Repeat founder rates exceeding 30% suggest positive portfolio company experiences and ongoing relationship value.

Sector-specific benchmarks vary significantly. Cybersecurity-focused funds like Team8 and YL Ventures have generated exceptional returns given strong strategic acquirer demand and the sector’s sustained growth. Enterprise software funds have benefited from high multiples and strong SaaS economics. Digital health funds show longer development timelines but strong strategic value when achieving clinical validation and regulatory approvals.

Notable Israeli VC performance examples include JVP’s early funds generating 5x+ returns, Aleph’s 2013 fund showing exceptional paper returns driven by multiple unicorns, and Viola’s consistent top-quartile performance across multiple vintages. These successes validate Israel’s position as a top-tier venture market deserving institutional allocation.

Establishing meaningful relationships with top venture capital firms in Israel requires strategic approach, patience, and leveraging ecosystem resources designed to facilitate connections between international investors and the Israeli innovation community.

Start-Up Nation Central serves as the primary gateway organization connecting international investors, corporations, and governments with Israeli innovation. This non-profit operates a comprehensive database of over 10,000 Israeli startups and maintains relationships with all major Israeli VCs. The organization offers customized innovation scouting, delegation programs, and introduction services tailored to specific sector interests and investment criteria.

International investors can engage with Start-Up Nation Central through several programs. The Innovation Discovery process provides customized mapping of Israeli companies and VCs aligned with specific thematic interests. Delegation programs bring groups of investors to Israel for curated meetings with VCs, entrepreneurs, and ecosystem stakeholders. The organization’s team includes sector specialists who can facilitate warm introductions to appropriate fund managers based on investment stage, sector focus, and strategic objectives.

Industry conferences and events provide concentrated networking opportunities with Israeli VC communities. OurCrowd Global Investor Summit attracts 20,000+ participants annually, including hundreds of VC investors and thousands of startup companies. The event features pitching competitions, panel discussions, and structured networking sessions. DLD Tel Aviv Innovation Festival brings together global technology leaders and Israeli innovators for two days of presentations and networking.

Sector-specific events like Cybertech (cybersecurity), MIXiii Biomed (life sciences), and FinTech Week provide focused environments for connecting with VCs specializing in particular domains. These events typically feature more substantive technical discussions and attract qualified investors seriously evaluating the sectors.

Direct outreach strategies should be researched and personalized. Top Israeli VCs receive hundreds of inbound inquiries monthly, so differentiation is essential. Effective outreach includes specific investment thesis alignment, relevant portfolio company interest, sector expertise demonstration, and clear value proposition for the relationship.

Initial contact should target partner-level individuals whose sector focus aligns with investor interests rather than generic fund email addresses. LinkedIn represents an effective channel for Israeli VCs who actively maintain professional profiles and engage with their networks. Referrals from existing LPs, portfolio company executives, or mutual contacts significantly increase response rates and meeting conversion.

Building relationships over time typically proves more effective than transactional approaches. Attending multiple Israeli events, engaging thoughtfully with VC content and portfolio company announcements, and demonstrating sustained interest in the ecosystem builds credibility. Many foreign investors successfully establish relationships by initially participating in platforms like OurCrowd, then graduating to direct fund investments as they build knowledge and networks.

Ecosystem intermediaries including Israeli law firms (Meitar, Herzog Fox & Neeman, Goldfarb Seligman), accounting firms (Kost Forer Gabbay, BDO Israel), and specialized consulting firms (IVC Research Center, Catalyst Investments) can facilitate introductions and provide market intelligence. These service providers maintain relationships across the VC community and often make introductions for clients showing serious interest.

Government and diplomatic channels offer additional connectivity pathways. The Israel Innovation Authority, Israeli Economic Mission offices in major financial centers, and bilateral chambers of commerce organize events and delegation programs specifically designed to connect foreign capital with Israeli innovation. These programs often provide subsidized access and governmental credibility that enhances meeting quality.

University and research institution connections provide alternative entry points. Many Israeli VCs maintain close relationships with Hebrew University, Technion, Tel Aviv University, and Weizmann Institute, which produce significant technology transfer opportunities. Engaging with university technology transfer offices and participating in commercialization programs can facilitate connections with VCs focused on deep-tech and scientific innovation.

For corporations seeking strategic technology partnerships, most top Israeli VCs operate corporate innovation programs that facilitate pilots, partnerships, and investment opportunities. These programs provide structured frameworks for engagement that align corporate innovation objectives with VC portfolio company capabilities.

Identifying the most active venture capital firms provides insight into which organizations maintain the strongest deal flow, market presence, and operational tempo in the Israeli ecosystem. Activity levels correlate with market influence, though raw deal volume doesn’t necessarily indicate investment quality.

Based on 2026 data from IVC Research Center and Start-Up Nation Central, OurCrowd leads in absolute deal volume, completing 80-100 new investments annually across its platform. This high activity reflects the platform’s crowdfunding model and relatively lower average check sizes compared to traditional institutional VCs.

Pitango Venture Capital maintains exceptionally high activity across its multi-stage platform, completing 40-50 new investments annually across seed, early-stage, growth, and healthtech funds. This volume reflects the firm’s size, multiple fund mandates, and comprehensive stage coverage.

Jerusalem Venture Partners completes 15-20 new platform investments annually, with additional investments through affiliated seed funds and accelerator programs. JVP’s activity concentrates in cybersecurity, enterprise infrastructure, and digital media sectors where the firm maintains specialized expertise.

Viola Group across its various funds completes 25-35 new investments annually, spanning early-stage equity through growth and credit instruments. The organization’s multi-product approach enables engagement across the company lifecycle.

Aleph maintains more selective activity with 8-12 new investments annually, reflecting its concentrated portfolio strategy and emphasis on deep partnership with fewer companies. Despite lower deal volume, Aleph’s selectivity and strong founder reputation enable access to premium opportunities.

Other highly active firms include 83North (12-15 deals annually), Glilot Capital Partners (15-20 deals focused on cybersecurity), Team8 (10-12 deals through its venture creation model), and Entree Capital (12-15 deals spanning Israel, Europe, and U.S.).

Sector specialists demonstrate concentrated activity within domains. YL Ventures completes 6-8 new cybersecurity investments annually, representing substantial activity within its narrow focus. Pitango HealthTech invests in 10-12 new digital health companies per year. Canaan Partners Israel maintains steady activity with 8-10 deals annually across enterprise technology.

Activity metrics should be evaluated alongside portfolio performance, as the highest-volume investors don’t necessarily generate the strongest returns. The most successful Israeli VCs typically balance sufficient activity to deploy capital efficiently while maintaining selectivity that ensures quality standards.

Understanding investment sizing across the Israeli VC landscape helps entrepreneurs set realistic fundraising expectations and enables investors to calibrate co-investment opportunities appropriately. Investment sizes vary significantly by fund stage focus, sector, and specific company maturity.

Seed-stage investments from Israeli VCs typically range from $500,000 to $3 million for initial rounds. Seed specialists like Firstime Ventures, Techstars Israel, and various angel groups operate at the lower end of this range, while seed programs from larger multi-stage firms like Pitango and Viola may invest $2-3 million when leading rounds for exceptional teams.

Accelerator programs including the Technion accelerator, Microsoft accelerator, and sector-specific programs typically provide $50,000-$250,000 in initial capital, often structured as convertible notes or SAFE instruments that convert in subsequent priced rounds.

Series A investments represent the primary focus for many leading Israeli VCs. Typical Series A rounds range from $5 million to $15 million in total, with lead investors contributing $3-8 million. Firms like Aleph, Vertex Ventures Israel, Canaan Partners, and Battery Ventures typically lead at this stage with investments in the $5-10 million range for companies demonstrating product-market fit and initial revenue traction.

Series A rounds in capital-intensive sectors like semiconductor technology or hardware may reach $15-20 million, while efficient SaaS businesses might raise $5-8 million. Israeli Series A rounds tend to be 20-30% smaller than U.S. equivalents for comparable companies, reflecting lower burn rates and more conservative growth strategies.

Series B investments typically range from $15 million to $40 million in total round size, with lead investors contributing $10-25 million. At this stage, international VCs increasingly participate alongside Israeli firms, with U.S. growth investors like Insight Partners, Battery Ventures, and Bessemer bringing significant capital and global market access.

Israeli-based growth investors including Pitango Growth, Viola Growth, and 83North actively compete for Series B leadership, typically investing $15-30 million per company. These rounds fund international expansion, particularly U.S. market entry, sales team scaling, and product development acceleration.

Growth-stage investments (Series C and beyond) range from $40 million to $200 million, with Israeli companies increasingly accessing global mega-funds. At this stage, firms like Insight Partners, Tiger Global, Coatue, and General Atlantic dominate, though Israeli investors often participate in insider rounds to maintain ownership positions.

Notable large rounds in 2026 include cybersecurity companies raising $100M+ growth rounds, digital health companies completing $60-80M Series C rounds, and fintech companies accessing $150M+ late-stage capital. These rounds typically involve minimal Israeli VC participation, with global investors leading and setting terms.

Follow-on investment capacity represents a critical consideration. Top Israeli VCs reserve 50-70% of fund capital for follow-on investments in portfolio companies, enabling continued ownership maintenance through subsequent rounds. Pro-rata rights ensure existing investors can participate in future rounds, though economic terms and investor selection become increasingly competitive as companies mature.

Sector variations significantly impact investment sizing. Cybersecurity companies often raise larger rounds given competitive dynamics and the need for global sales infrastructure. Enterprise software companies typically raise efficiently with smaller rounds. Hardware and deep-tech companies require substantial capital for R&D and manufacturing, pushing round sizes higher. Digital health companies face extended development timelines requiring multiple funding rounds before commercial revenue.

Understanding these investment size norms helps foreign investors calibrate co-investment opportunities, with Series A and B rounds offering optimal co-investment economics and portfolio construction characteristics for most institutional investors seeking Israeli technology exposure.